✦ LIBER ✦

Antenatal ambroxol treatment does not prevent the respiratory distress syndrome in premature infants

✍ Scribed by C. Dani; P. V. Grella; L. Lazzarin; F. F. Rubaltelli

Publisher: Springer
Year: 1997
Tongue: English
Weight: 67 KB
Volume: 156
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s004310050622

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early treatment of patent ductus arterio

Early treatment of patent ductus arteriosus in premature infants with severe respiratory distress syndrome

✍ Giacomo Pongiglione; Maurizio Marasini; Gilberto Silvestri; Pietro Tuo; Dionigi 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 392 KB

To the editor: Surfactant aerosol treatm

To the editor: Surfactant aerosol treatment of respiratory distress syndrome in spontaneously breathing premature infants

✍ Gerhard Jorch; Heike Hartl; Bernhard Roth; Angela Kribs; Ludwig Gortner; Thomas 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 2 views

Functional residual capacity and complia

Functional residual capacity and compliance of the respiratory system after surfactant treatment in premature infants with severe respiratory distress syndrome

✍ Jürgen Dinger; Andreas Töpfer; Peter Schaller; Roland Schwarze 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 97 KB

Efficiency of heparin in the treatment o

Efficiency of heparin in the treatment of newborn infants with respiratory distress syndrome and disseminated intravascular coagulation

✍ U. Göbel; H. Voss; H. Jürgens; C. Petrich; R. Pothmann; I. Sprock; P. Lemburg 📂 Article 📅 1980 🏛 Springer 🌐 English ⚖ 257 KB

Forty newborns with severe shock and disseminated intravascular coagulation were randomized for treatment with heparin or placebo. Mortality was equal in both groups. The heparin group required significantly shorter periods of artificial ventilation. The coagulation system improved faster, and the c

Glutathione-S-transferase-P1 I105V polym

Glutathione-S-transferase-P1 I105V polymorphism and response to antenatal betamethasone in the prevention of respiratory distress syndrome

✍ Chiara Oretti; Sara Marino; Fabio Mosca; Maria Rosa Colnaghi; Sara De Iudicibus; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 169 KB

Comparative trial of artificial and natu

Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: Experiences in a developing country

✍ David E. da Costa; M.G.K. Pai; Saleh M. Al Khusaiby 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 2 views

We conducted a randomized clinical trial to compare the effects of a synthetic (Exosurfா) and natural (Survantaா) surfactant in infants with neonatal respiratory distress syndrome. Eighty-nine patients were randomly allocated to receive one of the two surfactants. Primary outcome variables were the